Poll Finds Only Half of Americans Plan to Get COVID-19 Vaccine

Poll Finds Only Half of Americans Plan to Get COVID-19 Vaccine

A recent poll conducted by the Associated Press’s NORC Center for Public Affairs Research found that 20 percent of Americans anticipate that a COVID-19 vaccine will be available to the public before the end of 2020, while 61 percent expect it during 2021. Only 17 percent believe it will take longer than that to develop.1 […]

Pfizer and BioNTech Begin Human Clinical Trials of COVID-19 Vaccine in U.S.

Pfizer and BioNTech Begin Human Clinical Trials of COVID-19 Vaccine in U.S.

Pfizer, Inc. of New York and BioNTech SE of Mainz, Germany have announced that human clinical trials for an experimental COVID-19 vaccine they have co-developed, known as BNT162, have begun in the United States.1 As part of a global clinical development program, the first human subjects in the U.S. Phase I and Phase clinical II […]

Oxford Begins COVID-19 Vaccine Trials to Meet September Deadline

Oxford Begins COVID-19 Vaccine Trials to Meet September Deadline

On Mar. 17, 2020, European Commission (EC) president Ursula von der Leyen said she was hopeful a vaccine for COVID-19 could be available this September. Her view was based on conversations she had had with managers of German biotechnology firm CureVac AG which has developed an experimental messenger RNA (mRNA) vaccine that it plans to […]

COVID-19 Meltdown and Pharma’s Big Money Win

COVID-19 Meltdown and Pharma’s Big Money Win

Dr. Anthony Fauci, director of the National Institute for Allergy and Infectious Diseases (NIAID) told Americans on Apr. 1, 2020 that modeling reports suggested COVID-19 infections could eventually “kill 100,000 to 240,000 Americans,”1 2 3 which was considerably less than the worst case 1.7 million mortality figure the Centers for Disease Control and Prevention (CDC) […]

Moderna to Use New mRNA Technology to Develop Coronavirus Vaccine

Moderna to Use New mRNA Technology to Develop Coronavirus Vaccine

Story Highlights In light of the coronavirus outbreak, three research teams have been awarded grants by the Coalition for Epidemic Preparedness Innovations to develop a vaccine for the novel coronavirus. In a public-private partnership with NIH, Moderna, Inc. is using an experimental mRNA technology to develop a vaccine. Johnson & Johnson and other drug companies […]